Myqorzo, a selective small-molecule cardiac myosin inhibitor, is designed to improve functional capacity and relieve symptoms in oHCM
The injectable borofalan (10B), developed by CNNC Headway—a subsidiary of China Isotope & Radiation Corporation (CIRC) under the China National Nuclear Corporation (CNNC)—has officially entered Phase I clinical trials
Penumbra projects fourth-quarter revenue growth of 21.4% to 22.0%, with full-year 2025 revenue expected to reach approximately $1.4 billion
The updated closure system introduces intuitive handling, innovative functionality and a premium design compatible with a wide range of syringe formats
The BD Neopak Glass Prefillable Syringe platform is designed for the complex needs of biologics and combination products
CARsgen is working to transform outcomes for patients with solid tumors by advancing the potential of CAR T technologies
The trial also revealed statistically significant and clinically meaningful gains in key patient-reported outcomes
BFF provides bookable fermentation upscaling capacity, process expertise, and quality procedures for pilot campaigns, generating decision-grade data without companies needing to build their own facilities
AbbVie will offer reduced prices for its medicines in Medicaid and commit $100 billion over the next decade to US research, development and capital investments, including domestic manufacturing
Subscribe To Our Newsletter & Stay Updated
